Who is 'Lulu Direct S Tablets' suitable for?

Ideal for those suffering from severe cough and phlegm due to colds, and who want a non-drowsy formula safe for daytime use.

Available at pharmacies and drugstores as a Designated Category II OTC medicine. Launch date: August 31, 2026.

What is special about the 'Lulu' brand?

A long-selling brand since 1951, widely recognized as a household staple medicine in Japan.

What are the active ingredients?

Combines four antitussive agents and one expectorant (L-Carbocisteine) for comprehensive relief.

What is Daiichi Sankyo Healthcare's corporate mission?

'Fit for You – A Life Partner for Everyone’s Healthy Living,' promoting self-care and self-medication.

AI News NQ Analysis

New Launch of 'Lulu Direct S Tablets' <Launch Date: August 31, 2026 (Mon)>

NQ Score 50/100

N1 Content Completeness 5

AI Summary (NQ-processed)

Daiichi Sankyo Healthcare Co., Ltd. will launch 'Lulu Direct S Tablets,' a new cough and expectorant medication specifically formulated for severe cough and phlegm symptoms caused by colds, on August 31, 2026. The product is non-caffeinated and comes in a portable PTP sheet format.

AI Analysis

Frequently Asked Questions

Q: Who is 'Lulu Direct S Tablets' suitable for?: A: Ideal for those suffering from severe cough and phlegm due to colds, and who want a non-drowsy formula safe for daytime use.
Q: Where can I buy it?: A: Available at pharmacies and drugstores as a Designated Category II OTC medicine. Launch date: August 31, 2026.
Q: What is special about the 'Lulu' brand?: A: A long-selling brand since 1951, widely recognized as a household staple medicine in Japan.
Q: What are the active ingredients?: A: Combines four antitussive agents and one expectorant (L-Carbocisteine) for comprehensive relief.
Q: What is Daiichi Sankyo Healthcare's corporate mission?: A: 'Fit for You – A Life Partner for Everyone’s Healthy Living,' promoting self-care and self-medication.